A randomized double-blind crossover trial of intravenous lidocaine in the treatment of neuropathic cancer pain.
J Pain Symptom Manage
; 7(3): 138-40, 1992 Apr.
Article
em En
| MEDLINE
| ID: mdl-16967580
ABSTRACT
In a randomized, double-blind, crossover study, we evaluated the effect of intravenous lidocaine (5 mg/kg body weight over 30 min) on the neuropathic pain of advanced cancer patients. Pain intensity, assessed by a visual analogue scale, did not show any significant difference between lidocaine and placebo infusion. The blinded choice of patients and investigators also suggested no significant improvement from lidocaine when given by this regimen. Intravenous lidocaine does not appear to have a significant analgesic effect on neuropathic cancer pain.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Cuidados Paliativos
/
Assistência Terminal
/
Medição da Dor
/
Lidocaína
/
Neoplasias
/
Neuralgia
Tipo de estudo:
Clinical_trials
/
Etiology_studies
Limite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Pain Symptom Manage
Assunto da revista:
NEUROLOGIA
/
PSICOFISIOLOGIA
/
TERAPEUTICA
Ano de publicação:
1992
Tipo de documento:
Article
País de afiliação:
Canadá